Healthcare AI

Explore Healthcare AI through related topics and the articles other pages reference most.

Explore articles

Reset filters
Browse subtopics: AI for Science

Articles that also belong to these categories. Counts cover all of Healthcare AI.

Showing 1-12 of 12 articles

AI in drug discovery

AI in drug discovery (also called AI drug discovery) is the application of artificial intelligence, machine learning, deep learning, generative models, and natural language processing across the pharmaceutical…

AI Tools & ProductsAI for Science

AlphaGenome

AlphaGenome is a unified deep learning model developed by Google DeepMind that predicts thousands of functional genomic properties from raw DNA sequences.

AI ModelsAI for Science

AlphaMissense

AlphaMissense is a machine learning model from Google DeepMind that predicts whether a missense variant, a single amino-acid substitution in a protein, is likely to cause disease.

AI for ScienceGoogle DeepMind

Brain-Computer Interface

A brain-computer interface (BCI), also called a brain-machine interface, is a system that measures activity in the nervous system and translates it into commands for an external device, bypassing muscles and…

AI CompaniesAI for Science

C-BRAIN

C-BRAIN (the Consortium for Biomedical Research and AI in Neurodegeneration, styled "C-brAIn" in early coverage) is a consortium of academic researchers, pharmaceutical companies, philanthropic organizations…

AI for ScienceOpen Source AI

NewLimit

NewLimit is an American biotechnology company, headquartered in South San Francisco, California, that is developing medicines intended to restore youthful function to old cells through epigenetic reprogramming.

AI CompaniesAI for Science

Protein design

Protein design is the construction of new protein sequences that fold into an intended three-dimensional shape and perform an intended job, such as binding a chosen target, catalyzing a reaction, or assembling…

AI for ScienceDrug Discovery

Rentosertib

Rentosertib is an investigational oral small-molecule inhibitor of TNIK (TRAF2- and NCK-interacting kinase) developed by Insilico Medicine for idiopathic pulmonary fibrosis (IPF)

AI for ScienceDrug Discovery

Virtual Biology Initiative

The Virtual Biology Initiative is a five-year research program launched on April 29, 2026 by Biohub, the science organization of the Chan Zuckerberg Initiative (CZI), with a founding commitment of $500 million.

AI for Science